go to DCU Home
 
..\Images\People\ElmJordan.gif
  • Elm, Jordan, M.S., Ph.D.
  • Senior Biostatistician
  • Associate Professor of Biostatistics, Department of Public Health Sciences
  • College of Medicine, Medical University of South Carolina
  • Phone: 843-876-1605
  • Fax: 843.876.1923
  • Email: elmj@musc.edu
  • Experience: Phase II-III clinical trials; drugs and device trials
  • Research: Clinical Trial Methodology and Implementation, Adaptive/Flexible designs, Phase II designs
  • Projects: Parkinson’s disease, Neurological Emergencies, Stroke, Status Epilepticus
Jordan J. Elm, PhD, is an Assistant Professor of Biostatistics in the DPHS and is also a biostatistician for the DCU. She is funded by the NETT Network Statistical and Data Management Center and the NINDS Neuroprotection Exploratory Trials in Parkinson’s Disease (NET-PD) Statistical Center. She has been involved in the design, conduct, and analysis of multi-center, randomized phase II and phase III clinical trials in the areas of Parkinson’s disease, stroke, and emergency medicine. The development of adaptive trial designs, futility designs, measurement validation, and approaches to measuring neuroprotection in Neurology are areas of active research interest.

Publications
 

Presentations
 
  • Farrant M, Johnston C, Easton D, Kim AS, Barsan W, Elm J, Lindblad A, Palesch Y.
  • Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke. (Poster)
  • European Stroke Organization Conference, Prague, May 2017.
  • Zhao, W., Pauls, K., Dillon, C., Kim, J.,Arnaud, C.,Ellerbe, C.,Elm, J.
  • Architectural Design of Automated Study Drug Distribution Coordination Module Integrated in Web-Based Clinical Trial Management System.
  • 38th Annual Society for Clinical Trial Meeting, May 2017, Liverpool, UK
  • Farrant M, Johnston C, Easton D, Kim AS, Barsan W, Elm J, Lindblad A, Palesch Y.
  • Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke. (Poster)
  • International Stroke Conference, Los Angeles, Feb 2016.
  • Ellerbe CN, Elm J, Ramakrishnan V, Turnbull B, Durkalski V.
  • Bias correction and optimized patient allocation for seamless adaptive dose selection design with repeated measures.
  • May 2014. Society for Clinical Trials Annual Meeting. Philadelphia, PA. Oral.
  • Ellerbe CN, Elm J, Ramakrishnan V, Turnbull B, Jauch E, DeSantis S, Durkalski V.
  • Phase II/III Seamless Adaptive Dose Selection Design for Longitudinal Patient Data.
  • September 2013. FDA. White Oak, VA. Oral. Presented also at 2013 Joint Statistical Meeting and 2013 Society for Clinical Trials
  • Ellerbe CN, Elm J, Ramakrishnan V, Turnbull B, Jauch E, DeSantis S, Durkalski V.
  • Optimal Longitudinal Data Utilization in a Seamless Adaptive (SA) Phase II/III Clinical Trial - Use of the conditional test statistic to identify the correct patient allocation ratio at each trial phase.
  • February 2013. ASA Conference on Statistical Practice. New Orleans, LA. Poster.
  • Perlmutter A, Battenhouse H, Conner C, Dillon C, Elm J, Pauls K, Zhao W.
  • Adjudication of Safety Outcomes in a Web-Based Clinical Trial Management System.
  • Society for Clinical Trials Annual Meeting, May 2012, Miami, FL
go to DPHS

go to MUSC